OCBCO
TEVA icon

Oversea-Chinese Banking Corp (OCBC)’s Teva Pharmaceuticals TEVA Stock Holding History

Oversea-Chinese Banking Corp (OCBC)’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,651
Closed -$109K – 398
2023
Q3 		$109K Hold
10,651
– – ﹤0.01% 370
2023
Q2 		$80.2K Hold
10,651
– – ﹤0.01% 321
2023
Q1 		$94.3K Sell
10,651
-68,496
-87% -$677K ﹤0.01% 314
2022
Q4 		$722K Buy
+79,147
New +$691K 0.04% 186

Other funds holding TEVA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
IAM
Ion Asset Management Herzliya, Israel $911M AUM 24.97% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $5.06B AUM 91.14% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
SPC
Slate Path Capital New York $6.73B AUM 95.97% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Oversea-Chinese Banking Corp (OCBC)'s TEVA Position: Q4 2023 in Review

Oversea-Chinese Banking Corp (OCBC) sold out of Teva Pharmaceuticals (TEVA) in Q4 2023, closing a stake of 10,651 shares — an estimated $109K sold.

Oversea-Chinese Banking Corp (OCBC) first reported a position in TEVA in Q4 2022 and held it in 4 quarters. The position peaked at $722K in Q4 2022. 447 funds tracked by Wall St. Rank hold TEVA as of Q4 2023.

  • Oversea-Chinese Banking Corp (OCBC) reported no remaining Teva Pharmaceuticals position as of Q4 2023 after selling out during the quarter.
  • Oversea-Chinese Banking Corp (OCBC) sold 10,651 Teva Pharmaceuticals shares in Q4 2023, an estimated $109K.
  • Oversea-Chinese Banking Corp (OCBC) first reported a position in Teva Pharmaceuticals in Q4 2022 and held it in 4 quarters.
  • Oversea-Chinese Banking Corp (OCBC)'s Teva Pharmaceuticals position peaked at $722K in Q4 2022.
  • 447 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2023.

Based on Oversea-Chinese Banking Corp (OCBC)'s 13F filing for Q4 2023, filed 1 Feb 2024.